Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Veröffentlicht: |
Podgorica
Crnogorska akademija nauka i umjetnosti
2021.
|
| Schriftenreihe: | Odjeljenje prirodnih nauka
knjiga 53 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Literaturverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV048477535 | ||
| 003 | DE-604 | ||
| 005 | 20230302 | ||
| 007 | t | ||
| 008 | 220920s2021 yu |||| 00||| cnr d | ||
| 020 | |a 9788672155150 |9 978-86-7215-515-0 | ||
| 035 | |a (OCoLC)1346084498 | ||
| 035 | |a (DE-599)BVBBV048477535 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a cnr | |
| 044 | |a yu |c XA-ME | ||
| 049 | |a DE-12 | ||
| 084 | |a OST |q DE-12 |2 fid | ||
| 100 | 1 | |a Antunović, Vaso |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori |b = Epidemiological, clinical and demographic stroke features in Montenegro |c Vasa Antunović, Ranko Raičević, Jevto Eraković |
| 246 | 1 | 1 | |a Epidemiological, clinical and demographic stroke features in Montenegro |
| 264 | 1 | |a Podgorica |b Crnogorska akademija nauka i umjetnosti |c 2021. | |
| 300 | |a 95 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Posebna izdanja (Monografije i studije) / Crnogorska akademija nauka i umjetnosti |v knjiga 170 |a Odjeljenje prirodnih nauka |v knjiga 53 | |
| 500 | |a Auflage 150. - Literaturverzeichnis Seite 87-91 | ||
| 650 | 0 | 7 | |a Schlaganfall |0 (DE-588)4052588-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Montenegro |0 (DE-588)4040163-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Montenegro |0 (DE-588)4040163-7 |D g |
| 689 | 0 | 1 | |a Schlaganfall |0 (DE-588)4052588-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Raičević, Ranko |e Verfasser |4 aut | |
| 700 | 1 | |a Eraković, Jevto |e Verfasser |4 aut | |
| 830 | 0 | |a Odjeljenje prirodnih nauka |v knjiga 53 |w (DE-604)BV010626750 |9 170 | |
| 856 | 4 | 2 | |m Digitalisierung BSB München 19 - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung BSB München 19 - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Literaturverzeichnis |
| 940 | 1 | |n oe | |
| 940 | 1 | |q BSB_NED_20230302 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033855247 | ||
| 942 | 1 | 1 | |c 610.9 |e 22/bsb |f 090513 |g 49745 |
Datensatz im Suchindex
| _version_ | 1804184430170865664 |
|---|---|
| adam_text | SADRŽAJ Vaso Antunović UVODNE NAPOMENE............................................................................. 5 Ranko Raičević PREDGOVOR........................................................................................... 7 Ranko Raičević UVODNA RIJEČ...................................................................................... 11 OPŠTI DIO Ranko Raičević ISHEMIJSKI MOŽDANI UDAR............................................................. 19 Ranko Raičević LIJEČENJE ISHEMIJSKOG MOŽDANOG UDARA............................ 39 Vaso Antunović, Ranko Raičević i saradnici EPIDEMIOLOŠKE, KLINIČKE I DEMOGRAFSKE KARAKTERISTIKE MOŽDANOG UDARA U CRNOJ GORI................................................ 45 SPECIJALNI DIO Ranko Raičević, Vaso Antunović, Jefto Eraković ORIJENTIRI ZA RAD I RAZMIŠLJANJE............................................. 57 Ranko Raičević, Vaso Antunović, Jefto Eraković ZNAČAJ FAKTORA RIZIKA ZA NASTANAK MU............................ 63 Ranko Raičević DIJAGNOSTIČKI PROGRAM IMU....................................................... 67 Ranko Raičević, Vaso Antunović NEUROVASKULARNE TERAPIJSKE PROCEDURE I MU................75 Jefto Eraković MOŽDANI UDAR I TELEMEDICINA.................................................. 77 Ranko Raičević REZIME I POUKE IZ ŽIVOTA.............................................................. 83 LITERATURA........................................................................................................ 87 INDEKS POJMOVA...............................................................................................
93 Bavprs-c’ ·?
LITERATURA [1] Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med 1986; 315: 717-20. [2] Adams HP Jr, Putnam SF, Kassel NF, Tomer JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984; 41: 1033-35. [3] Agnoli A, Freschi C, Bozzao L, Battistini N, Prencipe Μ. Autoregulation of cere bral blood flow. Circulation 1968; 38: 800-12. [4] American Heart Association. 1993 Heart and Stroke Facts Statistics. Dallas, Tex: American Heart Association, 1992. [5] Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised tri als of antiplatelet therapy. In: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106. [6] Asplund K, Dahlen G, Olsson T, Viitanen Μ. Lipoprotein (a) and its relation to hypertension in patients with acute stroke. Stroke 1990; 21 (suppl): 191-195. [7] Assessment: transcranial Doppler: report of the American Academy of Neurol ogy. Therapeutics and Technology Assessment Subcommittee. Neurology 1990; 40: 680-81. [8] Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hem orrhage in stroke patients anticoagulated with heparin. Stroke 1989; 20:1500-3. [9] Bajtajić V, Tadic R. Arteriovenske malformacije mozga. Vojnosanit Pregl 1987; 44: 45-50. [10] Barnett HJ, Ellisaziw Μ, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995; 332: 238-48. [11] Barnett HJM, Kaste Μ, Meldrum H, Eliasziw Μ. Aspirin dose in stroke preven tive.
Stroke 1996; 27: 588-92. [12] Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988; 128:116-23. [13] Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325: 445-53. [14] Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92. [15] Bonita R, Beaglehole R, Asplund K. The worldwide problem of stroke. Curr Opin Neurol 1994; 7: 5-10. [16] Bonita R, Stewart A, Baeglehole R. International trends in stroke mortality. Stroke 1990; 21: 989-92.
88 Ranko Raičević [17] Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-44. [18] Brey IR, Hart GK, Sherman GD, Tgeler HC. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-6. [19] Brodal A. Neurological Anatomy. Oxford University Press, London 1981. [20] Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesotta, through 1989. Stroke 1996; 27: 373-80. [21] Caplan LR. Brain embolism revisited. Neurology 1993; 43: 1281-87. [22] Catto AJ, Grant PJ. Risk factors for cerebrovascular disease and the role of coag ulation anf fibrinolysis. Blood Coagul Fibrinolysis 1995; 6: 497-510. [23] Collen D, Lijnen HR. Fibrinolysis and the control of hemostasis. In: Stamatoyannopoulos G, Nienhuis AW, Majewrus PW, Varmus H (eds). Ihe Molecular Basis of Blood Diseases. WB Saunders, Philadelphia 1994; pp 725-52. [24] Davis WD, Hart RG. Cardiogenic stroke in elderly. Clin Geriatr Med 1991; 7: 429-44. [25] Djordjević D, Jovičič A, Regovié V, Raičević R. Increased titer of anticardiolipin antibodies represent the risk for the development of ischemic brain disease in persons below 50. Vojnosanit Pregl 1998; 55(suppl: 2): 15-21. [26] Drayer BP. Diseases of the cerebral vascular system. In: The Clinical Neurosciences. Vol 4: Neuroradiology. New York, Churchill Livingstone, 1984. pp. 247-360. [27] Fisher Μ, Prichard JW, Warach S. New magnetic resonance technique for acute ischemic stroke. JAMA 1995; 274: 908-11. [28] Green D. Anticoagulants. CRC Press. Boca Raton, 1994.
[29] Halkier T. Mechanisms in Blood Coagulation, Fibrinolysis and the Complement System. Cambridge University Press, Cambridge, 1991. [30] Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilem mas. Stroke 1988; 19: 937-40. [31] Ivanovič P. Svetomir. Specifičnosti faktora rizika cerebrovaskularnih oboljenja u Crnoj Gori. CANU, vol 35; 2011. [32] Jovičič A, Krgović Μ, Tavčiovski D, Raičević R. Cerebrokardijalni i kardiocerebralni sindromi. JPPTT Srbija, Beograd, 1998. [33] Lanska DJ, Kuller LH. Ihe geography of stroke mortality the United States and the concept of a stroke belt. Stroke 1995; 26: 1145-9. [34] Milenkovič Z, Radenkovič S, Babić Μ. Spontana subarahnoidna hemoragija, vazospazam i nimodipin. Grafika — Pirot. 1998. [35] Mršulja BB, Mićić DV. Slobodni radikali i značaj reperfuzije u cerebrovaskularnim bolestima. U Mršulja BB, Kostic VS, urednici. Biološki osnovi terapije cerebrovaskularne bolesti. Beograd: Medicinski fakultet, 1992; 66-73. [36] Nelson ML, Tanner MC, Van Den Eeden SK, McGuire MV. Neuroepidemiolo gy: From principles to practice. ISN-BN-13: 978-0195133790. Oxford Universi ty Press 2003. [37] Nunn DB. Carotid endarterectomy in patients with territorial transient ischem ic attacks. J Vase Surg 1988; 8: 447-52. [38] Paddock-Eliasziw LM, Eliasziw Μ, Barr HW, Barnett HJ. Neurology. Long-term prognosis and the effect of carotid endarterectomy in patients with recurrent ip silateral ischemic events. North American Symptomatic Carotid Endarterecto my Trial Group. Neurology 1996; 47: 1158-62.
LITERATURA 89 [39] Raičević R, Jovičič A, Krgović M, Tavčiovski D, Ratković N, Đorđević D, Dinčić E. Beta blokatori i ishemijska bolest mozga. Vojnosanit Pregl 1998; 55: 417-27. [40] Raičević R, Jovičič A, Minié Lj, Markovič Lj, Đorđević D, Ćirković S. Karotidnokavernozna fistula sa spontanom sanacijom. Vojnosanit Pregl 1998; 55:429-34. [41] Raičević R, Jovičić A, Tavčiovski D, Đorđević D, Krgović Μ. Klinički prediktori kardijalnih komplikacija kod bolesnika sa akutnom ishemijskom bolešću moz ga. Vojnosanit Pregl 1998; 55: 3-14. [42] Raičević R, Jovičić A, Veljančić D, Đorđević D, Čedić V, Dinčić E, Jović P. Značaj udruženosti faktora rizika od moždane ateroskleroze kod bolesnika sa akutnom ishemijskom bolešću mozga. Vojnosanit Pregl 1998; 55: 255-63. [43] Raičević R, Jovičić A, Tavčiovski D, Krgović Μ, Ratković N, Veljančić D, Đor đević D, Dinčić D. Analiza antihipertenzivne terapije kod bolesnika sa akutnom ishemijskom bolešću mozga pre neurološkog događaja. Vojnosanit Pregl 1998; 55: 469-75. [44] Raičević R, Jovičić A, Mandić-Radić S, Đorđević D. Hemostazni sistem i ishe mijska bolest mozga — specifičnosti vezane za moždanu cirkulaciju i kliničke implikacije. Vojnosanit Pregl 2002; 59: 523-29. [45] Raičević R, Jovičić A, Markovié Lj, Đorđević D, Aleksie P, Perić P, Kostic J. Mje sto i uloga endovaskularnih procedura u terapiji ishemijske bolesti mozga. Voj nosanit Pregl 2002; 59: 75-80. [46] Raičević R, Jovičić A, Tavčiovski D, Krgović Μ, Dinčić D, Markovič Lj, Ratko vić N, Spasić R. Ateroskleroza luka aorte — mogući etiopatogenetski činilac is hemijske bolesti
mozga. Vojnosanit Pregl 2002; 59: 169-76. [47] Raičević R, Jovičić A, Tavčiovski D, Markovič Lj, Vukotić N. Ponavljane epizo de fokalne moždane ishemije kod bolesnice sa prolapsom mitralne valvule i migrenskom glavoboljom. Vojnosanit Pregl 2002; 59: 81-85. [48] Raičević R. Hemostazni sistem i ishemijska bolest mozga. Beograd: Zadužbina Andrejević; 1999. [49] Kostić VS, Raičević R, urednici. Karotidna bolest. Beograd: Pangraf; 2004. [50] Raičević R, Petkovič S, Lepič T. Urednici. Osnovi vojne neurologije. Beograd: Vojna knjiga; 2004. [51] Raičević R, Kostić VS, urednici. Klasifikacije i kriterijumi u neurologiji. Beo grad: Inpres; 2006. [52] Raičević R, Jovičić A, Mandić-Radić S, Đorđević D, Markovié Lj, Veljančić D, Dinčić E, Obradović S. Prediktivna vrijednost promjena u hemostaznom siste mu kod bolesnika sa ishemijskom bolešću mozga. Vojnosanit Pregl 2002; 59: 377-84. [53] Selaković V, Čolić M, Jovanovič Μ, Raičević R, Jovičić A. Cerebrospinal fluid and plasma concentration of soluble intercellular adhesion molecule 1, vascu lar cell adhesion molecule 1 and endothelial leukocyte adhesion molecule in pa tients with acute ischemic brain disease. Vojnosanit Pregl 2003; 60: 139-146. [54] Selakovic V, Raičević R, Radenovic L. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. Journal of Clinical Neuroscience 2005; 12: 542-47. [55] Obradović D, Balint B, Dinčić E, Raičević R, Obradović S, Tončev G, Kostić V. Primena matičnih ćelija u lečenju neuroloških oboljenja — da li je
budućnost već stigla. Vojnosanit Pregl 2008; 65: 473-80.
90 Ranko Raičević [56] Jovanovic RD, Bumbaširević-Beslać Lj, Raičević R,. Zidverc-Trajković J, Ercegovac DM. Etiology of ischemic stroke among young adults of Serbia. Vojnosanit Pregl 2008; 65: 803-809. [57] Pekmezovic T, Svetel Μ, Ristie A, Raicevic R, Ivanovic N, Smiljkovic T, Kostic VS. Incidence of vascular hemibalism in the population of Belgrade. Mov Dis ord 2004; 1469-72. [58] Raicevic R. Stroke — a continuing epidemic. Vojnosanit Pregl 2009; 66: 777-8. [59] Djuric T, Zivković M, Radak D, Jekic D, Radak S, Stojkovič L, Raicevic R, Stank ovic A, Alavantic D. Association of MMP 3 5A-6A gene polymorphism with sus ceptibility to carotid atherosclerosis. Clin Biochem 2008; 1326-9. [60] Raičević R. Promjene u koagulaciono-antikoagulacionom sistemu kod bolesni ka sa ishemijskom bolešću mozga. Doktorska disertacija. Beograd: Vojnomedicinska akademija, 1998. [61] Raičević R. Značaj pojedinih promjena u EKG-u kod bolesnika sa akutnom is hemijskom bolešću mozga. Magistarski rad. Beograd: Vojnomedicinska akade mija, 1997. [62] Richards A, Graham D, Bullock R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry 1988; 51: 416-21. [63] Runge MS. Prevention of thrombosis and rethrombosis. New approaches. Cir culation 1990; 82: 655-63. [64] Sandercock P, Bamford J, Dennis Μ, Burn J, Slattery J, Jones L et al. Atrial fibrilation and stroke: prevalence in different types of stroke and influence on ear ly and long term prognosis. Oxfordshire community stroke project. BMJ 1992; 305: 1460-65. [65]
Scatton B. Excitatory amino acid receptor antagonists: a novel treatment for is chemic cerebrovascular diseases. Life Sci 1994; 55: 2115-24. [66] Sherman DG, Hart RG. Thromboembolism and antithrombotic therapy in cere brovascular disease. J Am Coll Cardiol 1986; 8: 88B-97B. [67] Sherman DG. Advances in stroke management. Neurology 1997; 49 (suppl 4): 1-2. [68] Sila CA. Neurologic complications of vascular surgery. Neurol Clin 1998; 16: 9-20. [69] Strefler JY, Furlan AJ, Barnett HJM. Cardiogenic brain embolism: incidence, va rieties, treatment. In: Barnett HJM, Mohr JP, Stein BM, Yarsu FM (eds). Stroke. Churchill-Livingstone, New York, 1992. pp 967-994. [70] Takano K, Yamaguchi T, Kato H, Omae T. Activation of coagulation in acute cardioembolic stroke. Stroke 1991; 22: 12-16. [71] Tavčiovski D. Doprinos transezofagealne ehokardiografije u dijagnozi trombotičnih masa srčanih šupljina i poremećaja odgovornih za nastanak ishemijske bolesti mozga. Doktorska disertacija. Beograd: Vojnomedicinska akademi ja, 1997. [72] The American-Canadian Co-opperative study group: Persantine-Aspirin trial in cerebral ischemia. Stroke 1983; 14:99-103. [73] The ESPS Group. The European Stroke Prevention Study (ESPS): principal and points. Lancet 1987; 2: 1351-54. [74] The Multicenter Acute Stroke Trial — Europe Study Group. Thrombolytic thera py with streptokinase in acute ischemic stroke. N Engl J Med 1996; 335:145-50.
LITERATURA 91 [75] The SASS Investigators. Ganglioside GMl in acute ischemic stroke. The SASS Trial. Stroke 1994; 25:1141-48. [76] Wade DT, Hewer RL. Functional abilites after stroke: measurement, natural his tory and prognosis, ƒ Neurol Neurosurg Psychiatry 1987; 50:177-82. [77] Warley PF, Barban JM, Snyder SH. Beyond receptors: multiple second messenger system in brain. Ann Neurol 1987; 21: 217-29. [78] Warlow C. Carotid endarterectomy: does it work. Stroke 1984; 15:1068-76. [79] Webster MWI, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM. Pat ent foramen ovale in young stroke patients. Lancet 1988; 2: 11-2. [80] Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early re sults of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemi ol 1992; 2: 471-80. [81] Yasaka Μ, Yamaguchi T. Cardioembolic stroke revealed by increased hemostatic markers associated with intracardiac thrombus. Stroke 1991; 22: 1317-19. [82] Zivin JA. Factors determining the therapeutic window for stroke. Neurology 1998; 50: 599-603. [83] Zlokovic BV, Wang L, Schreiber SS. Haemostatic functions of the blood-brain barrier: possible implications in the pathogenesis of stroke. In: Greenwood J, Begley DJ, Segal MB (eds). New Concepts of a Blood Brain Barrier. Plenum, New York, 1995. pp 141-145. [84] Zlokovic BV, Wang L, Sun N et al. Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier. Neurosurgery 1995; 37: 955-61. [85]
Zubkov AY, Lewis AI, Scalzo D, Bernanke DH, Harkey HL. Morphological changes after percutaneous transluminal angioplasty. Surg Neurol. 1999; 51: 399-403.
|
| adam_txt |
SADRŽAJ Vaso Antunović UVODNE NAPOMENE. 5 Ranko Raičević PREDGOVOR. 7 Ranko Raičević UVODNA RIJEČ. 11 OPŠTI DIO Ranko Raičević ISHEMIJSKI MOŽDANI UDAR. 19 Ranko Raičević LIJEČENJE ISHEMIJSKOG MOŽDANOG UDARA. 39 Vaso Antunović, Ranko Raičević i saradnici EPIDEMIOLOŠKE, KLINIČKE I DEMOGRAFSKE KARAKTERISTIKE MOŽDANOG UDARA U CRNOJ GORI. 45 SPECIJALNI DIO Ranko Raičević, Vaso Antunović, Jefto Eraković ORIJENTIRI ZA RAD I RAZMIŠLJANJE. 57 Ranko Raičević, Vaso Antunović, Jefto Eraković ZNAČAJ FAKTORA RIZIKA ZA NASTANAK MU. 63 Ranko Raičević DIJAGNOSTIČKI PROGRAM IMU. 67 Ranko Raičević, Vaso Antunović NEUROVASKULARNE TERAPIJSKE PROCEDURE I MU.75 Jefto Eraković MOŽDANI UDAR I TELEMEDICINA. 77 Ranko Raičević REZIME I POUKE IZ ŽIVOTA. 83 LITERATURA. 87 INDEKS POJMOVA.
93 Bavprs-c’ ·?
LITERATURA [1] Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med 1986; 315: 717-20. [2] Adams HP Jr, Putnam SF, Kassel NF, Tomer JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984; 41: 1033-35. [3] Agnoli A, Freschi C, Bozzao L, Battistini N, Prencipe Μ. Autoregulation of cere bral blood flow. Circulation 1968; 38: 800-12. [4] American Heart Association. 1993 Heart and Stroke Facts Statistics. Dallas, Tex: American Heart Association, 1992. [5] Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised tri als of antiplatelet therapy. In: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106. [6] Asplund K, Dahlen G, Olsson T, Viitanen Μ. Lipoprotein (a) and its relation to hypertension in patients with acute stroke. Stroke 1990; 21 (suppl): 191-195. [7] Assessment: transcranial Doppler: report of the American Academy of Neurol ogy. Therapeutics and Technology Assessment Subcommittee. Neurology 1990; 40: 680-81. [8] Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hem orrhage in stroke patients anticoagulated with heparin. Stroke 1989; 20:1500-3. [9] Bajtajić V, Tadic R. Arteriovenske malformacije mozga. Vojnosanit Pregl 1987; 44: 45-50. [10] Barnett HJ, Ellisaziw Μ, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995; 332: 238-48. [11] Barnett HJM, Kaste Μ, Meldrum H, Eliasziw Μ. Aspirin dose in stroke preven tive.
Stroke 1996; 27: 588-92. [12] Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988; 128:116-23. [13] Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325: 445-53. [14] Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92. [15] Bonita R, Beaglehole R, Asplund K. The worldwide problem of stroke. Curr Opin Neurol 1994; 7: 5-10. [16] Bonita R, Stewart A, Baeglehole R. International trends in stroke mortality. Stroke 1990; 21: 989-92.
88 Ranko Raičević [17] Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-44. [18] Brey IR, Hart GK, Sherman GD, Tgeler HC. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190-6. [19] Brodal A. Neurological Anatomy. Oxford University Press, London 1981. [20] Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesotta, through 1989. Stroke 1996; 27: 373-80. [21] Caplan LR. Brain embolism revisited. Neurology 1993; 43: 1281-87. [22] Catto AJ, Grant PJ. Risk factors for cerebrovascular disease and the role of coag ulation anf fibrinolysis. Blood Coagul Fibrinolysis 1995; 6: 497-510. [23] Collen D, Lijnen HR. Fibrinolysis and the control of hemostasis. In: Stamatoyannopoulos G, Nienhuis AW, Majewrus PW, Varmus H (eds). Ihe Molecular Basis of Blood Diseases. WB Saunders, Philadelphia 1994; pp 725-52. [24] Davis WD, Hart RG. Cardiogenic stroke in elderly. Clin Geriatr Med 1991; 7: 429-44. [25] Djordjević D, Jovičič A, Regovié V, Raičević R. Increased titer of anticardiolipin antibodies represent the risk for the development of ischemic brain disease in persons below 50. Vojnosanit Pregl 1998; 55(suppl: 2): 15-21. [26] Drayer BP. Diseases of the cerebral vascular system. In: The Clinical Neurosciences. Vol 4: Neuroradiology. New York, Churchill Livingstone, 1984. pp. 247-360. [27] Fisher Μ, Prichard JW, Warach S. New magnetic resonance technique for acute ischemic stroke. JAMA 1995; 274: 908-11. [28] Green D. Anticoagulants. CRC Press. Boca Raton, 1994.
[29] Halkier T. Mechanisms in Blood Coagulation, Fibrinolysis and the Complement System. Cambridge University Press, Cambridge, 1991. [30] Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilem mas. Stroke 1988; 19: 937-40. [31] Ivanovič P. Svetomir. Specifičnosti faktora rizika cerebrovaskularnih oboljenja u Crnoj Gori. CANU, vol 35; 2011. [32] Jovičič A, Krgović Μ, Tavčiovski D, Raičević R. Cerebrokardijalni i kardiocerebralni sindromi. JPPTT Srbija, Beograd, 1998. [33] Lanska DJ, Kuller LH. Ihe geography of stroke mortality the United States and the concept of a stroke belt. Stroke 1995; 26: 1145-9. [34] Milenkovič Z, Radenkovič S, Babić Μ. Spontana subarahnoidna hemoragija, vazospazam i nimodipin. Grafika — Pirot. 1998. [35] Mršulja BB, Mićić DV. Slobodni radikali i značaj reperfuzije u cerebrovaskularnim bolestima. U Mršulja BB, Kostic VS, urednici. Biološki osnovi terapije cerebrovaskularne bolesti. Beograd: Medicinski fakultet, 1992; 66-73. [36] Nelson ML, Tanner MC, Van Den Eeden SK, McGuire MV. Neuroepidemiolo gy: From principles to practice. ISN-BN-13: 978-0195133790. Oxford Universi ty Press 2003. [37] Nunn DB. Carotid endarterectomy in patients with territorial transient ischem ic attacks. J Vase Surg 1988; 8: 447-52. [38] Paddock-Eliasziw LM, Eliasziw Μ, Barr HW, Barnett HJ. Neurology. Long-term prognosis and the effect of carotid endarterectomy in patients with recurrent ip silateral ischemic events. North American Symptomatic Carotid Endarterecto my Trial Group. Neurology 1996; 47: 1158-62.
LITERATURA 89 [39] Raičević R, Jovičič A, Krgović M, Tavčiovski D, Ratković N, Đorđević D, Dinčić E. Beta blokatori i ishemijska bolest mozga. Vojnosanit Pregl 1998; 55: 417-27. [40] Raičević R, Jovičič A, Minié Lj, Markovič Lj, Đorđević D, Ćirković S. Karotidnokavernozna fistula sa spontanom sanacijom. Vojnosanit Pregl 1998; 55:429-34. [41] Raičević R, Jovičić A, Tavčiovski D, Đorđević D, Krgović Μ. Klinički prediktori kardijalnih komplikacija kod bolesnika sa akutnom ishemijskom bolešću moz ga. Vojnosanit Pregl 1998; 55: 3-14. [42] Raičević R, Jovičić A, Veljančić D, Đorđević D, Čedić V, Dinčić E, Jović P. Značaj udruženosti faktora rizika od moždane ateroskleroze kod bolesnika sa akutnom ishemijskom bolešću mozga. Vojnosanit Pregl 1998; 55: 255-63. [43] Raičević R, Jovičić A, Tavčiovski D, Krgović Μ, Ratković N, Veljančić D, Đor đević D, Dinčić D. Analiza antihipertenzivne terapije kod bolesnika sa akutnom ishemijskom bolešću mozga pre neurološkog događaja. Vojnosanit Pregl 1998; 55: 469-75. [44] Raičević R, Jovičić A, Mandić-Radić S, Đorđević D. Hemostazni sistem i ishe mijska bolest mozga — specifičnosti vezane za moždanu cirkulaciju i kliničke implikacije. Vojnosanit Pregl 2002; 59: 523-29. [45] Raičević R, Jovičić A, Markovié Lj, Đorđević D, Aleksie P, Perić P, Kostic J. Mje sto i uloga endovaskularnih procedura u terapiji ishemijske bolesti mozga. Voj nosanit Pregl 2002; 59: 75-80. [46] Raičević R, Jovičić A, Tavčiovski D, Krgović Μ, Dinčić D, Markovič Lj, Ratko vić N, Spasić R. Ateroskleroza luka aorte — mogući etiopatogenetski činilac is hemijske bolesti
mozga. Vojnosanit Pregl 2002; 59: 169-76. [47] Raičević R, Jovičić A, Tavčiovski D, Markovič Lj, Vukotić N. Ponavljane epizo de fokalne moždane ishemije kod bolesnice sa prolapsom mitralne valvule i migrenskom glavoboljom. Vojnosanit Pregl 2002; 59: 81-85. [48] Raičević R. Hemostazni sistem i ishemijska bolest mozga. Beograd: Zadužbina Andrejević; 1999. [49] Kostić VS, Raičević R, urednici. Karotidna bolest. Beograd: Pangraf; 2004. [50] Raičević R, Petkovič S, Lepič T. Urednici. Osnovi vojne neurologije. Beograd: Vojna knjiga; 2004. [51] Raičević R, Kostić VS, urednici. Klasifikacije i kriterijumi u neurologiji. Beo grad: Inpres; 2006. [52] Raičević R, Jovičić A, Mandić-Radić S, Đorđević D, Markovié Lj, Veljančić D, Dinčić E, Obradović S. Prediktivna vrijednost promjena u hemostaznom siste mu kod bolesnika sa ishemijskom bolešću mozga. Vojnosanit Pregl 2002; 59: 377-84. [53] Selaković V, Čolić M, Jovanovič Μ, Raičević R, Jovičić A. Cerebrospinal fluid and plasma concentration of soluble intercellular adhesion molecule 1, vascu lar cell adhesion molecule 1 and endothelial leukocyte adhesion molecule in pa tients with acute ischemic brain disease. Vojnosanit Pregl 2003; 60: 139-146. [54] Selakovic V, Raičević R, Radenovic L. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. Journal of Clinical Neuroscience 2005; 12: 542-47. [55] Obradović D, Balint B, Dinčić E, Raičević R, Obradović S, Tončev G, Kostić V. Primena matičnih ćelija u lečenju neuroloških oboljenja — da li je
budućnost već stigla. Vojnosanit Pregl 2008; 65: 473-80.
90 Ranko Raičević [56] Jovanovic RD, Bumbaširević-Beslać Lj, Raičević R,. Zidverc-Trajković J, Ercegovac DM. Etiology of ischemic stroke among young adults of Serbia. Vojnosanit Pregl 2008; 65: 803-809. [57] Pekmezovic T, Svetel Μ, Ristie A, Raicevic R, Ivanovic N, Smiljkovic T, Kostic VS. Incidence of vascular hemibalism in the population of Belgrade. Mov Dis ord 2004; 1469-72. [58] Raicevic R. Stroke — a continuing epidemic. Vojnosanit Pregl 2009; 66: 777-8. [59] Djuric T, Zivković M, Radak D, Jekic D, Radak S, Stojkovič L, Raicevic R, Stank ovic A, Alavantic D. Association of MMP 3 5A-6A gene polymorphism with sus ceptibility to carotid atherosclerosis. Clin Biochem 2008; 1326-9. [60] Raičević R. Promjene u koagulaciono-antikoagulacionom sistemu kod bolesni ka sa ishemijskom bolešću mozga. Doktorska disertacija. Beograd: Vojnomedicinska akademija, 1998. [61] Raičević R. Značaj pojedinih promjena u EKG-u kod bolesnika sa akutnom is hemijskom bolešću mozga. Magistarski rad. Beograd: Vojnomedicinska akade mija, 1997. [62] Richards A, Graham D, Bullock R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry 1988; 51: 416-21. [63] Runge MS. Prevention of thrombosis and rethrombosis. New approaches. Cir culation 1990; 82: 655-63. [64] Sandercock P, Bamford J, Dennis Μ, Burn J, Slattery J, Jones L et al. Atrial fibrilation and stroke: prevalence in different types of stroke and influence on ear ly and long term prognosis. Oxfordshire community stroke project. BMJ 1992; 305: 1460-65. [65]
Scatton B. Excitatory amino acid receptor antagonists: a novel treatment for is chemic cerebrovascular diseases. Life Sci 1994; 55: 2115-24. [66] Sherman DG, Hart RG. Thromboembolism and antithrombotic therapy in cere brovascular disease. J Am Coll Cardiol 1986; 8: 88B-97B. [67] Sherman DG. Advances in stroke management. Neurology 1997; 49 (suppl 4): 1-2. [68] Sila CA. Neurologic complications of vascular surgery. Neurol Clin 1998; 16: 9-20. [69] Strefler JY, Furlan AJ, Barnett HJM. Cardiogenic brain embolism: incidence, va rieties, treatment. In: Barnett HJM, Mohr JP, Stein BM, Yarsu FM (eds). Stroke. Churchill-Livingstone, New York, 1992. pp 967-994. [70] Takano K, Yamaguchi T, Kato H, Omae T. Activation of coagulation in acute cardioembolic stroke. Stroke 1991; 22: 12-16. [71] Tavčiovski D. Doprinos transezofagealne ehokardiografije u dijagnozi trombotičnih masa srčanih šupljina i poremećaja odgovornih za nastanak ishemijske bolesti mozga. Doktorska disertacija. Beograd: Vojnomedicinska akademi ja, 1997. [72] The American-Canadian Co-opperative study group: Persantine-Aspirin trial in cerebral ischemia. Stroke 1983; 14:99-103. [73] The ESPS Group. The European Stroke Prevention Study (ESPS): principal and points. Lancet 1987; 2: 1351-54. [74] The Multicenter Acute Stroke Trial — Europe Study Group. Thrombolytic thera py with streptokinase in acute ischemic stroke. N Engl J Med 1996; 335:145-50.
LITERATURA 91 [75] The SASS Investigators. Ganglioside GMl in acute ischemic stroke. The SASS Trial. Stroke 1994; 25:1141-48. [76] Wade DT, Hewer RL. Functional abilites after stroke: measurement, natural his tory and prognosis, ƒ Neurol Neurosurg Psychiatry 1987; 50:177-82. [77] Warley PF, Barban JM, Snyder SH. Beyond receptors: multiple second messenger system in brain. Ann Neurol 1987; 21: 217-29. [78] Warlow C. Carotid endarterectomy: does it work. Stroke 1984; 15:1068-76. [79] Webster MWI, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM. Pat ent foramen ovale in young stroke patients. Lancet 1988; 2: 11-2. [80] Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early re sults of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemi ol 1992; 2: 471-80. [81] Yasaka Μ, Yamaguchi T. Cardioembolic stroke revealed by increased hemostatic markers associated with intracardiac thrombus. Stroke 1991; 22: 1317-19. [82] Zivin JA. Factors determining the therapeutic window for stroke. Neurology 1998; 50: 599-603. [83] Zlokovic BV, Wang L, Schreiber SS. Haemostatic functions of the blood-brain barrier: possible implications in the pathogenesis of stroke. In: Greenwood J, Begley DJ, Segal MB (eds). New Concepts of a Blood Brain Barrier. Plenum, New York, 1995. pp 141-145. [84] Zlokovic BV, Wang L, Sun N et al. Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier. Neurosurgery 1995; 37: 955-61. [85]
Zubkov AY, Lewis AI, Scalzo D, Bernanke DH, Harkey HL. Morphological changes after percutaneous transluminal angioplasty. Surg Neurol. 1999; 51: 399-403. |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Antunović, Vaso Raičević, Ranko Eraković, Jevto |
| author_facet | Antunović, Vaso Raičević, Ranko Eraković, Jevto |
| author_role | aut aut aut |
| author_sort | Antunović, Vaso |
| author_variant | v a va r r rr j e je |
| building | Verbundindex |
| bvnumber | BV048477535 |
| ctrlnum | (OCoLC)1346084498 (DE-599)BVBBV048477535 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02338nam a2200469 cb4500</leader><controlfield tag="001">BV048477535</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230302 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220920s2021 yu |||| 00||| cnr d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9788672155150</subfield><subfield code="9">978-86-7215-515-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1346084498</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048477535</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">cnr</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">yu</subfield><subfield code="c">XA-ME</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">OST</subfield><subfield code="q">DE-12</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Antunović, Vaso</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori</subfield><subfield code="b">= Epidemiological, clinical and demographic stroke features in Montenegro</subfield><subfield code="c">Vasa Antunović, Ranko Raičević, Jevto Eraković</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Epidemiological, clinical and demographic stroke features in Montenegro</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Podgorica</subfield><subfield code="b">Crnogorska akademija nauka i umjetnosti</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">95 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Posebna izdanja (Monografije i studije) / Crnogorska akademija nauka i umjetnosti</subfield><subfield code="v">knjiga 170</subfield><subfield code="a">Odjeljenje prirodnih nauka</subfield><subfield code="v">knjiga 53</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Auflage 150. - Literaturverzeichnis Seite 87-91</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schlaganfall</subfield><subfield code="0">(DE-588)4052588-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Montenegro</subfield><subfield code="0">(DE-588)4040163-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Montenegro</subfield><subfield code="0">(DE-588)4040163-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Schlaganfall</subfield><subfield code="0">(DE-588)4052588-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raičević, Ranko</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eraković, Jevto</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Odjeljenje prirodnih nauka</subfield><subfield code="v">knjiga 53</subfield><subfield code="w">(DE-604)BV010626750</subfield><subfield code="9">170</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung BSB München 19 - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung BSB München 19 - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Literaturverzeichnis</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="n">oe</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">BSB_NED_20230302</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033855247</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="c">610.9</subfield><subfield code="e">22/bsb</subfield><subfield code="f">090513</subfield><subfield code="g">49745</subfield></datafield></record></collection> |
| geographic | Montenegro (DE-588)4040163-7 gnd |
| geographic_facet | Montenegro |
| id | DE-604.BV048477535 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T20:38:14Z |
| indexdate | 2024-07-10T09:39:13Z |
| institution | BVB |
| isbn | 9788672155150 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033855247 |
| oclc_num | 1346084498 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 95 Seiten |
| psigel | BSB_NED_20230302 |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Crnogorska akademija nauka i umjetnosti |
| record_format | marc |
| series | Odjeljenje prirodnih nauka |
| series2 | Posebna izdanja (Monografije i studije) / Crnogorska akademija nauka i umjetnosti Odjeljenje prirodnih nauka |
| spelling | Antunović, Vaso Verfasser aut Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro Vasa Antunović, Ranko Raičević, Jevto Eraković Epidemiological, clinical and demographic stroke features in Montenegro Podgorica Crnogorska akademija nauka i umjetnosti 2021. 95 Seiten txt rdacontent n rdamedia nc rdacarrier Posebna izdanja (Monografije i studije) / Crnogorska akademija nauka i umjetnosti knjiga 170 Odjeljenje prirodnih nauka knjiga 53 Auflage 150. - Literaturverzeichnis Seite 87-91 Schlaganfall (DE-588)4052588-0 gnd rswk-swf Montenegro (DE-588)4040163-7 gnd rswk-swf Montenegro (DE-588)4040163-7 g Schlaganfall (DE-588)4052588-0 s DE-604 Raičević, Ranko Verfasser aut Eraković, Jevto Verfasser aut Odjeljenje prirodnih nauka knjiga 53 (DE-604)BV010626750 170 Digitalisierung BSB München 19 - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung BSB München 19 - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Literaturverzeichnis |
| spellingShingle | Antunović, Vaso Raičević, Ranko Eraković, Jevto Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro Odjeljenje prirodnih nauka Schlaganfall (DE-588)4052588-0 gnd |
| subject_GND | (DE-588)4052588-0 (DE-588)4040163-7 |
| title | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro |
| title_alt | Epidemiological, clinical and demographic stroke features in Montenegro |
| title_auth | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro |
| title_exact_search | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro |
| title_exact_search_txtP | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro |
| title_full | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro Vasa Antunović, Ranko Raičević, Jevto Eraković |
| title_fullStr | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro Vasa Antunović, Ranko Raičević, Jevto Eraković |
| title_full_unstemmed | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori = Epidemiological, clinical and demographic stroke features in Montenegro Vasa Antunović, Ranko Raičević, Jevto Eraković |
| title_short | Epidemiološke, kliničke i demografske karakteristike moždanog udara u Crnoj Gori |
| title_sort | epidemioloske klinicke i demografske karakteristike mozdanog udara u crnoj gori epidemiological clinical and demographic stroke features in montenegro |
| title_sub | = Epidemiological, clinical and demographic stroke features in Montenegro |
| topic | Schlaganfall (DE-588)4052588-0 gnd |
| topic_facet | Schlaganfall Montenegro |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033855247&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV010626750 |
| work_keys_str_mv | AT antunovicvaso epidemioloskeklinickeidemografskekarakteristikemozdanogudaraucrnojgoriepidemiologicalclinicalanddemographicstrokefeaturesinmontenegro AT raicevicranko epidemioloskeklinickeidemografskekarakteristikemozdanogudaraucrnojgoriepidemiologicalclinicalanddemographicstrokefeaturesinmontenegro AT erakovicjevto epidemioloskeklinickeidemografskekarakteristikemozdanogudaraucrnojgoriepidemiologicalclinicalanddemographicstrokefeaturesinmontenegro AT antunovicvaso epidemiologicalclinicalanddemographicstrokefeaturesinmontenegro AT raicevicranko epidemiologicalclinicalanddemographicstrokefeaturesinmontenegro AT erakovicjevto epidemiologicalclinicalanddemographicstrokefeaturesinmontenegro |